Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005089462 | SCV005837968 | likely pathogenic | RYR1-related disorder | 2024-04-29 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 3606 of the RYR1 protein (p.Leu3606Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal recessive RYR1-related conditions (PMID: 16621918, 27363342). ClinVar contains an entry for this variant (Variation ID: 65958). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Gene |
RCV000056205 | SCV000087294 | pathologic | Central core myopathy | 2010-05-11 | no assertion criteria provided | curation | Converted during submission to Pathogenic. |
RYR1 database | RCV000119419 | SCV000154326 | not provided | not provided | no assertion provided | not provided |